Clinical Trials Logo

Clinical Trial Summary

Hypotension is a common side-effect of general anesthesia induction and is related to adverse outcomes including significantly increasing risk of one-year mortality. Even short durations of intraoperative hypotension have been associated with acute kidney injury (AKI) and myocardial injury.Half of all the patients were fluid-responsive, pointing to volume status as a significant risk factor. Ultrasound measurements of inferior vena cava (IVC) diameter with respiration, including the maximal diameter of the IVC (dIVCmax) at the end of expiration during spontaneous respiration and the collapsibility index (CI), have been recommended as rapid and noninvasive methods for estimating volume status. In attempt to prevent hypotension after spinal anesthesia induction, Ondansetron, a serotonin receptor antagonist, has been used effectively . Research Question Can preoperative IVC-US guided fluid optimization and intravenous ondansetron reduce the incidence of general anesthesia-induced hypotension in adult patients undergoing elective non-cardiac non-obstetric surgery?


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05784350
Study type Interventional
Source Meir Medical Center
Contact Sara Dichtwald, Dr
Phone 972-9-7472133
Email sara.dichtwald@clalit.org.il
Status Not yet recruiting
Phase N/A
Start date December 1, 2024
Completion date May 1, 2028

See also
  Status Clinical Trial Phase
Not yet recruiting NCT01451294 - Effect of Blood Pressure on rSO2 in Carotid Endarterectomy (CEA) N/A